Fresh Tracks Therapeutics, Inc. financial data

Location
Boulder, CO
Fiscal year end
31 December
Latest financial report
10-K - Q4 2023 - 15 Mar 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 597% % 31%
Return On Equity -59% % 65%
Return On Assets -49% % 63%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5,973,306 shares 1.1%
Common Stock, Shares, Outstanding 5,973,306 shares 98%
Entity Public Float $4,100,000 USD -72.48%
Common Stock, Value, Issued $60,000 USD 100%
Weighted Average Number of Shares Outstanding, Basic 5,394,551 shares 92%
Weighted Average Number of Shares Outstanding, Diluted 5,394,551 shares 92%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $8,006,000 USD 15%
Research and Development Expense $3,182,000 USD -77.34%
General and Administrative Expense $11,184,000 USD -22.52%
Operating Income (Loss) $-6,360,000 USD 70%
Net Income (Loss) Attributable to Parent $-5,694,000 USD 73%
Earnings Per Share, Basic -1 USD/shares 86%
Earnings Per Share, Diluted -1 USD/shares 86%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $10,868,000 USD 25%
Other Assets, Current $7,000 USD -12.5%
Assets, Current $11,552,000 USD 15%
Property, Plant and Equipment, Net $34,000 USD -54.67%
Operating Lease, Right-of-Use Asset $0 USD -100%
Assets $11,586,000 USD 13%
Accounts Payable, Current $406,000 USD -28.9%
Employee-related Liabilities, Current $232,000 USD -82.42%
Accrued Liabilities, Current $1,250,000 USD -49.12%
Liabilities, Current $1,656,000 USD -46.18%
Retained Earnings (Accumulated Deficit) $-172,163,000 USD -3.42%
Stockholders' Equity Attributable to Parent $9,930,000 USD 38%
Liabilities and Equity $11,586,000 USD 13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-4,485,000 USD 53%
Net Cash Provided by (Used in) Financing Activities $6,569,000 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 5,973,306 shares 98%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,084,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10,868,000 USD 25%
Deferred Tax Assets, Valuation Allowance $131,694,000 USD -0.28%
Deferred Tax Assets, Gross $131,694,000 USD -0.28%
Operating Lease, Liability $19,000 USD -47.22%
Depreciation $10,000 USD 43%
Lessee, Operating Lease, Liability, to be Paid $19,000 USD -48.65%
Operating Lease, Liability, Current $0 USD -100%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,000 USD -50%
Deferred Tax Assets, Operating Loss Carryforwards $106,071,000 USD 1.7%
Additional Paid in Capital $182,033,000 USD 4.8%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $1,919,000 USD -10.99%
Interest Expense $5,000 USD -44.44%